Condition: Osteoarthritis · Osteo Arthritis Knee · Osteo Arthritis Shoulders · Sponsor: Healeon Medical Inc
Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical interventions have not yielded convincing long-term outcomes, including total joint replacement surgeries and medical management of the supportive structures. This study is to use a person's own stem/stromal Cells (autologous) plus HD-PRP (important healing growth factors and signal molecules) in such cases of OA for long-term minimally invasive treatments. Baseline (existing) findings are documented, and thence tracked as to progress deemed to be result of the intervention.
This description comes directly from the study's public registry record.
Donna Alderman, DO · 1 661 295 1110 · hemwallcenter@prolotherapy.com
Kathy Cirricione, BS · 1 661 295 1110 · hemwallcenter@gmail.com
Always discuss trial participation with your own doctor first.
| Hemwall Center for Orthopedic Regenerative Medicine | Valencia, California, United States | Recruiting |
| Regenevita LLC | Stevensville, Montana, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04238143